methylprednisolone aceponate: Clinical Trials

4 trials of methylprednisolone aceponate, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 2 Phase 4, 1 Not applicable, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 42Completed 2
Not applicable1Completed 1
Phase 11Completed 1

Follow methylprednisolone aceponate: new trials by email Literature Review of methylprednisolone aceponate trials Research Report on methylprednisolone aceponate

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Prevention of Development of Transcutaneous Sensitization in Children With Atopic Dermatitis During Their First Year of Life
Pimecrolimus cream 1%, cream 0.1% methylprednisolone aceponate - Atopic Dermatitis
Phase 4CompletedNational Medical Research Center for Children's Health, Russian Federation1082017-12-102021-05-27
Assess Itch Behavior in Nickel Sulphate Sensitized Volunteers
Adventan® (methylprednisolone aceponate 0,1%) - Allergic Contact Eczema
Phase 1CompletedFundacion IMIM182012-02-012016-05-12
Efficacy and Safety Study of Advantan for Maintenance Treatment of Atopic Dermatitis
Methylprednisolone Aceponate (Advantan, BAY86-4862), Placebo - Dermatitis, Atopic
Phase 4CompletedLEO Pharma2502005-03-012023-06-09
Evaluation of Topical Antipsoriatics in the Psoriasis Plaque Test
Protopic, Advantan, Blood and Urine Test, coherence tomography - Psoriasis Vulgaris
Not applicableCompletedTechnische Universität Dresden142004-09-012010-06-08

Conditions studied

Dermatitis, Atopic (2)

Sponsors

Fundacion IMIM (1)  ·  LEO Pharma (1)  ·  National Medical Research Center for Children's Health, Russian Federation (1)  ·  Technische Universität Dresden (1)

Countries

Germany (1)  ·  Russia (1)  ·  Spain (1)

Top investigators

Gottfried Wozel, Professor (1)

Results publications

PMID 37181420

NIH funding

2004 (1)